N-Me-DL-Phg-OH

N-Me-DL-Phg-OH is a DL mixture of N-methylated phenylglycine (Phg) bearing a free carboxylic acid, providing a chiral amino acid framework with a stereogenic center at the alpha carbon. The N-methyl substituent reduces the availability of the amide-forming nitrogen for conventional peptide coupling while maintaining a nucleophilic carboxyl functionality for esterification and amidation strategies. The phenyl side chain contributes hydrophobic and aromatic interaction potential, making the compound relevant to peptidomimetic design and conformationally constrained analog construction. As a chiral amino acid intermediate, N-Me-DL-Phg-OH can be transformed into protected derivatives or activated carboxylic acid forms to support downstream synthesis of substituted amino acid building blocks and amide-containing targets.

1. Peptidomimetic Synthesis

N-Me-DL-Phg-OH supports peptidomimetic construction in medicinal chemistry and chemical biology by providing an N-methylated amino acid motif paired with a phenyl side chain. The N-methyl group enforces an amide-like nitrogen substitution pattern in the resulting linkages, which can influence backbone conformation and protease recognition when incorporated into peptide analogs. The free carboxylic acid enables conversion to activated esters or coupling-ready intermediates for amide bond formation with amine partners under standard peptide chemistry conditions. The DL stereochemical nature can be leveraged for rapid SAR exploration when stereochemical resolution is not yet required, followed by later enantiomer-specific optimization through chiral separation or asymmetric downstream steps.

2. Protected Amino Acid Chemistry

N-Me-DL-Phg-OH is suitable for protected amino acid synthesis because the carboxylic acid can be selectively functionalized while the N-methylated amine can be maintained as an unprotected nucleophile state depending on the target protection scheme. The presence of a single stereogenic center at the alpha carbon supports stereochemically defined intermediate preparation when paired with chiral resolution workflows for the DL mixture. Carboxyl protection as an ester or acid derivative can facilitate orthogonal coupling sequences in multi-step peptide building block assembly, while the aromatic side chain remains chemically stable under many protection and deprotection regimes. Downstream, protected derivatives derived from N-Me-DL-Phg-OH can serve as intermediates for C-terminal modification, fragment coupling, and synthesis of N-methyl-containing amino acid units used in peptide science.

3. Chemical Biology Labeling

N-Me-DL-Phg-OH can be applied in chemical biology labeling and molecular probe synthesis through its carboxylic acid handle for conjugation to linkers, dyes, or affinity tags. The phenylglycine side chain provides a hydrophobic/aromatic element that can modulate binding to protein pockets or receptor-like targets in probe scaffolds, while the N-methylated backbone unit can alter local conformational preferences relative to standard amino acids. Carboxyl activation enables formation of amide or ester linkages to biomolecule-reactive moieties, supporting construction of small-molecule probes and peptide-like tags. DL stereochemistry may be used for initial probe generation and screening, with later stereochemical refinement possible when probe binding selectivity or stability depends on absolute configuration.

4. SAR And Molecular Design

N-Me-DL-Phg-OH is relevant to structure-activity relationship studies and molecular design workflows that require systematic variation of backbone substitution patterns and aromatic side-chain placement. The N-methylated amino acid structure provides a defined modification point that can be incorporated into analog series to probe how N-substitution affects conformation, hydrogen-bonding capacity, and metabolic stability proxies. The free carboxylic acid supports modular derivatization into salts, esters, or amide-linked fragments, enabling consistent scaffold assembly across SAR libraries. The phenyl side chain can participate in hydrophobic packing and aromatic interactions, making N-Me-DL-Phg-OH a practical chiral amino acid intermediate for generating libraries of substituted peptide mimetics and constrained amino acid analogs.

5. Process Chemistry Intermediate

N-Me-DL-Phg-OH serves as a process chemistry intermediate for fine chemical synthesis where amino acid derivative manufacturing requires reliable functional group interconversion at the carboxyl and stable handling of the N-methylated amine. The carboxylic acid functionality supports scalable conversion to activated intermediates used for downstream amidation or esterification steps, while the aromatic phenyl side chain remains compatible with common protection-group strategies. DL availability can simplify early-stage manufacturing routes for library synthesis by avoiding immediate enantiomer-specific steps, with optional downstream resolution if stereochemical purity becomes necessary for later development stages. The compound's role as a chiral amino acid intermediate aligns with industrial workflows that transform amino acid building blocks into protected derivatives, coupling reagents, and peptide-scaffold fragments for specialty chemical production.

1. Quantitative Analysis of Ligands Effects on Bioefficacy of Nanoemulsion encapsulating Depigmenting Active

2. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII

3. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment

4. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

5. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging